Hydroxyzine for Patients with Dry Cough
Hydroxyzine is not recommended for patients with dry cough as it is not included in evidence-based treatment algorithms for cough management. Instead, established antitussives should be used based on cough type and duration.
Evaluation and Classification of Cough
Before selecting treatment, determine cough characteristics:
- Duration: Acute (<3 weeks) vs. chronic (>8 weeks) 1
- Type: Dry/non-productive vs. productive/wet cough
- Underlying cause: Viral URI, asthma, GERD, etc.
Treatment Algorithm for Dry Cough
First-line options:
Over-the-counter glycerol-based cough syrups containing dextromethorphan
First-generation antihistamine/decongestant combinations
- Recommended as initial empiric treatment for chronic cough 1
- Particularly effective when cough is related to upper airway cough syndrome
Second-line options (if first-line fails):
- Opioid antitussives:
Third-line options:
- Peripherally acting antitussives like levodropropizine
Important Considerations and Precautions
- Hydroxyzine is not mentioned in any of the clinical practice guidelines for cough management
- Avoid mucokinetic agents in dry cough as they show no consistent favorable effects 1, 2
- Use caution with antitussives in specific populations:
When to Consider Further Evaluation
Refer for further investigation if the cough presents with:
- Hemoptysis
- Prominent systemic illness
- Suspicion of inhaled foreign body
- Suspicion of lung cancer 1
- Persistent cough despite appropriate treatment
Conclusion
For dry cough, begin with dextromethorphan-containing preparations or first-generation antihistamine/decongestant combinations. If these fail, consider opioid antitussives. Hydroxyzine is not included in evidence-based treatment algorithms for cough management and therefore should not be used for this indication.